Belvedere Trading
PLXP

Belvedere Trading’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Belvedere Trading’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,109
Closed -$263K – 649
2021
Q2 		$263K Buy
+13,109
New +$155K 0.02% 166

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Belvedere Trading's PLXP Position: Q3 2021 in Review

Belvedere Trading sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2021, closing a stake of 13,109 shares — an estimated $263K sold.

Belvedere Trading first reported a position in PLXP in Q2 2021 and held it in 1 quarter. The position peaked at $263K in Q2 2021. 63 funds tracked by Wall St. Rank hold PLXP as of Q3 2021.

  • Belvedere Trading reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Belvedere Trading sold 13,109 PLx Pharma Inc. Common Stock shares in Q3 2021, an estimated $263K.
  • Belvedere Trading first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Belvedere Trading's PLx Pharma Inc. Common Stock position peaked at $263K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2021.

Based on Belvedere Trading's 13F filing for Q3 2021, filed 19 Oct 2021.